However, biomarkers including urine NGAL and urine tissue inhibitor of metalloproteinase-2 (TIMP-2) didn’t predict the mortality among decompensated cirrhotic patients with AKI and patients with community-acquired AKI [42,43]. The gene discussed is LCN2; the disease is acute kidney injury.